Shenzhen Salubris Pharmaceuticals Co., Ltd.

This early-stage study aims to see if a new drug called SAL023 acts similarly in the body to an existing osteoporosis drug, Evenity. It will involve 118 healthy Chinese adults who will receive a single injection of one of the drugs. Researchers will primarily measure how the body…